iRhythm Holdings, Inc. (IRTC) Quick Ratio
- Quick ratio · latest quarter: Value 3.44×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 3.44× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $675.55M ÷ $196.10M ≈ 3.44× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 675.55M USD | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 196.10M USD | Liabilities, Current |
| Cash and equivalents | 246.68M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 344.60M USD | Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 84.27M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 22.51M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $675.55M | $196.10M | $246.68M | $344.60M | $84.27M | $22.51M | 3.44× |
| 2026-03-31 | $630.48M | $131.75M | $240.15M | $309.47M | $80.86M | $23.80M | 4.79× |
| 2025-12-31 | $659.47M | $151.89M | $236.01M | $347.75M | $75.71M | $21.63M | 4.34× |
| 2025-09-30 | $641.37M | $146.91M | $255.60M | $309.61M | $76.16M | $19.56M | 4.37× |
| 2025-06-30 | $627.69M | $132.21M | $309.11M | $236.44M | $82.15M | $18.40M | 4.75× |
| 2025-03-31 | $601.23M | $111.34M | $375.28M | $145.31M | $80.64M | $14.34M | 5.40× |
| 2024-12-31 | $615.49M | $110.92M | $419.60M | $115.96M | $79.94M | $14.04M | 5.55× |
| 2024-09-30 | $599.46M | $100.10M | $519.53M | $2.50M | $77.43M | $15.03M | 5.99× |
| 2024-06-30 | $646.97M | $97.89M | $550.55M | $10.90M | $85.51M | $15.43M | 6.61× |
| 2024-03-31 | $658.80M | $96.84M | $520.42M | $48.67M | $89.71M | $14.87M | 6.80× |
| 2023-12-31 | $195.25M | $107.37M | $36.17M | $97.59M | $61.48M | $13.97M | 1.82× |
| 2023-09-30 | $208.54M | $102.29M | $47.48M | $111.00M | $50.07M | $13.65M | 2.04× |
| 2023-06-30 | $215.85M | $89.41M | $61.58M | $103.16M | $51.11M | $14.48M | 2.41× |
| 2023-03-31 | $225.89M | $81.90M | $52.80M | $123.53M | $49.56M | $16.39M | 2.76× |
| 2022-12-31 | $263.06M | $89.10M | $78.83M | $134.31M | $49.92M | $15.15M | 2.95× |
| 2022-09-30 | $264.07M | $83.59M | $71.22M | $132.32M | $60.53M | $14.45M | 3.16× |
| 2022-06-30 | $261.87M | $70.42M | $101.25M | $103.24M | $57.38M | $14.42M | 3.72× |
| 2022-03-31 | $264.07M | $61.78M | $94.79M | $114.00M | $55.29M | $12.45M | 4.27× |
| 2021-12-31 | $285.56M | $87.85M | $127.56M | $111.57M | $46.43M | $10.27M | 3.25× |
| 2021-09-30 | $309.59M | $82.78M | $167.37M | $89.40M | $52.82M | $9.96M | 3.74× |
| 2021-06-30 | $319.09M | $73.02M | $138.87M | $116.79M | $63.42M | $9.26M | 4.37× |
| 2021-03-31 | $322.27M | $59.38M | $137.38M | $124.91M | $59.98M | $6.86M | 5.43× |
| 2020-12-31 | $365.15M | $65.67M | $88.63M | $246.59M | $29.93M | $5.31M | 5.56× |
| 2020-09-30 | $356.19M | $55.87M | $95.34M | $231.90M | $28.95M | $5.06M | 6.38× |
| 2020-06-30 | $137.80M | $47.31M | $81.73M | $33.20M | $22.88M | $4.99M | 2.91× |
| 2020-03-31 | $145.98M | $42.84M | $56.51M | $65.26M | $24.21M | $4.23M | 3.41× |
| 2019-12-31 | $164.42M | $52.07M | $20.46M | $120.09M | $23.87M | $4.04M | 3.16× |
| 2019-09-30 | $177.73M | $45.47M | $34.63M | $118.09M | $25.00M | $3.50M | 3.91× |
| 2019-06-30 | $88.53M | $35.65M | $16.15M | $43.24M | $29.14M | $2.77M | 2.48× |
| 2019-03-31 | $86.99M | $28.55M | $28.23M | $30.51M | $28.25M | $2.50M | 3.05× |
| 2018-12-31 | $100.32M | $30.24M | $20.02M | $58.32M | $21.98M | $2.06M | 3.32× |
| 2018-09-30 | $101.64M | $22.26M | $17.34M | $63.83M | $20.46M | $2.32M | 4.57× |
| 2018-06-30 | $104.98M | $19.66M | $19.24M | $66.67M | $19.07M | $2.17M | 5.34× |
| 2018-03-31 | $107.91M | $16.94M | $16.47M | $74.27M | $17.16M | $1.86M | 6.37× |
| 2017-12-31 | $120.89M | $20.92M | $8.67M | $99.27M | $12.95M | $1.68M | 5.78× |
| 2017-09-30 | $137.90M | $16.04M | $20.43M | $105.44M | $12.04M | $1.31M | 8.60× |
| 2017-06-30 | $133.74M | $15.20M | $16.25M | $106.64M | $10.85M | $1.23M | 8.80× |
| 2017-03-31 | $117.99M | $10.68M | $15.58M | $91.42M | $10.98M | $1.16M | 11.05× |
| 2016-12-31 | $161.39M | $13.21M | $51.64M | $100.34M | $9.41M | $1.39M | 12.21× |
| 2016-09-30 | (m) | $9.32M | $5.76M | (m) | $9.31M | $1.67M | (m) |
| 2016-06-30 | (m) | (m) | $8.97M | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | $14.24M | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $8.78M | $25.21M | (m) | $5.58M | $1.15M | (m) |
| 2015-09-30 | (m) | (m) | $7.13M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $8.62M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $7.10M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |